CClinicalTrials.gg
CompletedNCT06064955Pair 2 CareUpdated Feb 13, 2025Results posted

Pair 2 Care: Peer Support for Caregivers of Black Americans Living With Dementia

An interventional study of Peer Support in Family Caregiver, Dementia and Peer Support, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-13.

Sponsored by Ohio State University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to test a peer support intervention for caregivers who are caring for a loved one living with dementia.

Read the detailed description

African Americans are twice as likely to develop Alzheimer's disease or a related form of dementia (ADRD) than their White counterparts. These individuals are, however, more often diagnosed later, creating additional physical, spiritual, psychosocial challenges for both the person living with ADRD and their family caregivers. African American ADRD caregivers are therefore at greater risk for adverse physiological and psychological health effects of caregiving, including significant burden and stress. Evidence suggests that peer to peer support using storytelling may be effective in assisting ADRD caregivers with surrogate healthcare decision making, an important aspect of palliative care. Access to and use of palliative care, a recognized approach to serious illness care symptom management, among African Americans are low. The impact of this healthcare inequity further reduces the quality of life for African American ADRD caregivers and subsequently their care recipients. Prior approaches to serious illness care have failed to address the needs of African Americans living with ADRD from a palliative care perspective. This inability to meet their needs leads to increased unmet caregiver needs. Peer mentorship, a relationship-centered person-to-person approach may reduce healthcare decision making burden within cultural groups such as African Americans through cultural tailoring by promoting oral traditions, personal contact, and storytelling. Our current study includes perspectives of lower socioeconomic status African American ADRD caregivers who have expressed the need for person-centered, non-judgmental, on-demand, culturally congruent caregiving support for advance care planning and healthcare decision making. Simultaneously, former caregivers retrospectively described perceived benefits of peer support while caregiving and their willingness to serve as peer mentors to current caregivers. Additional data from healthcare provider and community stakeholders support the need and potential benefits of peer support for ADRD caregivers. Based on these preliminary findings, there is an urgent need and exciting opportunity to address the unmet palliative care needs of current caregivers through peer support. For this innovative project, investigators will use the experiential expertise of former caregivers to help current caregivers with advance care planning and healthcare decision making. The purpose of this project is to use a stakeholder-informed approach in further developing and pilot testing the co-created Peer Support for Caregivers of African Americans Living with Alzheimer's Disease and Related Dementias (Pair2Care), a culturally sensitive caregiver peer support intervention.

Aim: Conduct feasibility and acceptability testing of Pair 2 Care in current and trained former African American ADRD family caregiver peers paired based on congruent identity traits (e.g., relationship to care recipient, gender identity, etc.). Investigators will determine if Pair2Care is feasible and acceptable by evaluating satisfaction and appropriateness of the intervention for broader dissemination.

02

Conditions studied

  • Family Caregiver
  • Dementia
  • Peer Support

Browse trials for

Keywords

  • African American/Black
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's enrollment of 15 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • African-American
  • English-speaking
  • Adult (18+)
  • Family caregivers of people living with dementia (current or former)

Exclusion criteria

Exclusion Criteria:

  • Non-African-American
  • Non-English-speaking
  • Under age 18
  • Non-Family caregiver
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Peer Support

    Former caregivers will be paired with a current caregivers

    Behavioral: Peer Support

Interventions

  • BehavioralPeer Support

    Former caregivers will be paired with a current caregiver based on a similar personal attribute (e.g., relationship to care recipient). Each pair will complete at least five virtual face-to-face (video) interactions and at least 10 other interactions either via phone call, email, or text messaging over the 6-month time period.

06

What researchers measure

Primary outcomes

  1. Medical Outcomes Study Social Support Survey (MOS SSS)

    This instrument contains 19 items that comprise 4 subscales: Emotional/Informational Support, Tangible Support, Affectionate Support, and Positive Social Interaction. Each item is scored on a 5 point Likert scale of 1 ("none of the time") to 5 ("all the time"), with higher scores indicating more social support. Total and subscale scores are in a range of 1-5 calculated by taking the mean across items.

    Time frame: Baseline and 6 months post baseline

07

Results

Posted Feb 13, 2025

Participant flow

Participant flow — Overall Study
MilestonePeer Support
Started15
Completed14
Not completed1

Outcome measures

PrimaryMedical Outcomes Study Social Support Survey (MOS SSS)

This instrument contains 19 items that comprise 4 subscales: Emotional/Informational Support, Tangible Support, Affectionate Support, and Positive Social Interaction. Each item is scored on a 5 point Likert scale of 1 ("none of the time") to 5 ("all the time"), with higher scores indicating more social support. Total and subscale scores are in a range of 1-5 calculated by taking the mean across items.

Time frame:
Baseline and 6 months post baseline
Reported as:
Mean · score on a scale
Medical Outcomes Study Social Support Survey (MOS SSS)
score on a scalePeer Support
Emotional/Informational Support at Baseline3.75 ± 1.03
Emotional/Informational Support at 6 Months3.79 ± 0.99
Tangible support at Baseline3.68 ± 1.02
Tangible support at 6 months3.50 ± 1.29
Affectionate support at Baseline4.22 ± 0.67
Affectionate support at 6 months3.95 ± 0.90
Positive social interaction at Baseline4.11 ± 0.72
Positive social interaction at 6 months3.98 ± 0.83
Overall social support at Baseline3.88 ± 0.75
Overall social support at 6 months3.77 ± 0.83

Adverse events

Collected over Adverse event data were collected over the 6 month study period. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Peer Support0/15 (0%)0/15 (0%)0/15 (0%)

Baseline characteristics

Age, Customized
Age, Customized(years)Peer Support
Mean59.6 ± 13.5
Sex: Female, Male
Sex: Female, Male(Participants)Peer Support
Female15
Male0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Peer Support
Hispanic or Latino0
Not Hispanic or Latino14
Unknown or Not Reported1
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Peer Support
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American15
White0
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Peer Support
United States15
Marital Status
Marital Status(Participants)Peer Support
Single3
Separated/Divorced3
Married8
Widowed1
Employment
Employment(Participants)Peer Support
Full-time7
Part-time2
Homemaker1
Not employed, retired5
Relationship to loved one with dementia
Relationship to loved one with dementia(Participants)Peer Support
Spouse2
Daughter10
Son0
Other relative0
Friend/Neighbor0
Other3

1 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Ohio State University College of Nursing
    Columbus, Ohio 43210, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 15, 2024
  • Informed consent form · Aug 2, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06064955
Lead sponsor
Ohio State University
Collaborators
Cambia Health Foundation
Responsible party
Karen Moss (Assistant Professor, Ohio State University) — Principal investigator
First posted
Oct 3, 2023
Start date
Oct 5, 2023
Primary completion
Jul 11, 2024
Completion
Jul 11, 2024
Results posted
Feb 13, 2025
Last update
Feb 13, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion